喉頭
Online ISSN : 2185-4696
Print ISSN : 0915-6127
ISSN-L : 0915-6127
パネルディスカッション1 「高齢者喉頭癌の治療戦略」
高齢者に対する喉頭癌の放射線治療
古平 毅
著者情報
ジャーナル フリー

2021 年 33 巻 02 号 p. 108-113

詳細
抄録

Radiotherapy plays an essential role in the function-preserving treatment of elderly patients with laryngeal cancer. Regarding early glottic cancer (GC), accelerated fractionated radiotherapy (Ax) is believed to be a useful treatment option for GC because of its convenience in reducing the treatment time, cost, and labor. In JCOG 0701, Ax showed comparable efficacy and safety to standard fractionated radiotherapy. In addition, real-world data and evidence from clinical research have also shown promising findings concerning Ax for GC. Regarding radiation techniques for advanced laryngeal cancer, intensity-modulated radiation therapy (IMRT) is very useful for reducing late toxicity, especially for concurrent chemoradiotherapy (CCRT). Less-invasive treatment using IMRT is now being evaluated in many on-going trials, and the JCOG1912 trial has just started to assess the non-inferiority in less-invasive treatment in CCRT using IMRT for locally advanced head and neck cancer. We herein report the results of our organized prospective observation study for patients using radiotherapy with cetuximab in the JROSG12-2 trial. I sincerely appreciate the opportunity to introduce our findings at the 33rd annual meeting of the Japan Laryngological Association.

著者関連情報
© 2021 日本喉頭科学会
前の記事 次の記事
feedback
Top